Should I Buy CURV? CURV 2026 Analysis

Should You Buy Torrid Holdings Inc (CURV) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Sell

Latest Price

1.180

1 Day change

3.51%

52 Week Range

6.950

Analysis Updated At

2026/02/04

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now: trend is decisively bearish (SMA_200 > SMA_20 > SMA_5 + negative/expanding MACD), and fundamentals/Street revisions are still deteriorating.
Even though RSI (~30) is near oversold (could spark bounces), there is no proprietary signal or clear catalyst to justify an impatient entry.
Intellectia Proprietary Trading Signals
AI Stock Picker: no signal on given stock today.
SwingMax: No signal on given stock recently.

Technical Analysis

Trend: Bearish structure with moving averages stacked down (SMA_200 > SMA_20 > SMA_5), indicating persistent downtrend.
Momentum: MACD histogram -0.0128 below zero and negatively expanding => downside momentum is strengthening, not stabilizing.
RSI: RSI_6 at 30.149 (near oversold). This can enable short-term dead-cat bounces, but it’s not a confirmed reversal signal by itself.
Key levels: Pivot 1.199 is the first major reclaim level. Near-term support S1 1.123 and S2 1.076; a break below 1.076 risks fresh lows.
Pattern-based projection (similar candlesticks): +0.47% next day, +1.92% next week, +7.7% next month—positive skew, but it conflicts with current bearish momentum and lacks confirmation.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Positioning: Put/Call OI ratio 0.02 (calls heavily outweigh puts) => skewed bullish positioning, but can also signal speculative/lottery-call behavior at low prices.
Activity: Options volume is effectively 0 today (no meaningful flow confirmation).
Volatility: 30D IV 113.18 vs HV 65.5; IV percentile 89.24 => very expensive options pricing and elevated uncertainty.
OI snapshot: Call OI 2575 vs Put OI 58 (total OI 2633) => sentiment is call-heavy, but without volume it’s not a strong real-time signal.

Technical Summary

Sell

Buy

Positive Catalysts

- Potential technical bounce risk: RSI near 30 (oversold-ish) can produce short-lived rebounds.
- Losses improved YoY (EPS -0.06 vs much worse prior year), suggesting some cost/expense progress.
- No fresh negative news in the past week (but this is more “absence of catalyst” than a true positive).

Neutral/Negative Catalysts

- Downtrend intact with weakening momentum (negative/expanding MACD + bearish MA stack).
- Revenue decline persists (latest quarter revenue -10.85% YoY), indicating ongoing demand/traffic/merchandising pressure.
- Analysts broadly cut targets after weak execution and guidance reductions; narrative remains “execution miss + margin pressure.”
- No insider/hedge fund accumulation signals provided (both marked neutral), and no event-driven catalyst visible.

Financial Performance

Latest reported quarter: 2026/Q3.
Revenue: 235.153M, -10.85% YoY (core top-line trend still contracting).
Profitability: Net income -6.426M (still a loss) but improved materially YoY; EPS -0.06 improved YoY.
Margins: Gross margin 34.95%, down -1.24% YoY => margin pressure remains a key issue even as losses narrow.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Clear negative trend: multiple firms lowered price targets following a challenged quarter and guidance cuts.
Goldman Sachs: Sell, PT cut to $0.75 (guarded; profit under pressure; weak sales trends).
Morgan Stanley: Underweight, PT $1.01 (product mis-execution; third consecutive FY guidance cut).
Telsey: Market Perform, PT $2 (merchandising missteps, higher promotions/costs).
BofA: Buy but PT slashed to $2 (acknowledges execution challenges and margin pressure; still sees upside but with reduced confidence).
Wall Street pros/cons view: Pros—possible upside if execution improves and losses keep narrowing. Cons—repeated execution issues, weakening sales, and margin pressure are dominating the thesis right now.

6 Analyst Rating

Wall Street analysts forecast CURV stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CURV is 1.44 USD with a low forecast of 0.75 USD and a high forecast of 2 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

3 Hold

2 Sell

Hold

Current: 1.140

Low

0.75

Averages

1.44

High

Current: 1.140

Low

0.75

Averages

1.44

High

Goldman Sachs

Brooke Roach

Sell

downgrade

AI Analysis

2025-12-05

Reason

Goldman Sachs

Brooke Roach

Price Target

AI Analysis

2025-12-05

downgrade

Sell

Reason

Goldman Sachs analyst Brooke Roach lowered the firm's price target on Torrid to 75c from $1.50 and keeps a Sell rating on the shares. This was a "disappointing" update from Torrid and the firm is "incrementally" guarded on the business, the analyst tells investors. Profit is under significant pressure and sales trends remain weak, the firm adds.

Telsey Advisory

Market Perform

downgrade

$3 -> $2

2025-12-04

Reason

Telsey Advisory

Price Target

$3 -> $2

2025-12-04

downgrade

Market Perform

Reason

Telsey Advisory lowered the firm's price target on Torrid to $2 from $3 and keeps a Market Perform rating on the shares. The company's Q3 results were "challenged" due to merchandising missteps, higher promotions, and operating costs, the analyst tells investors.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for CURV

Unlock Now

CURV Should I Buy

CURV Should I Buy

Should You Buy Torrid Holdings Inc (CURV) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch